DreaMed Diabetes

Petah Tiqva, Israel

DreaMed Diabetes offers AI solutions and personalized support for optimized insulin therapy.

$3.0M raised

Aug 2024

Venture - Series Unknown

Artificial Intelligence (AI)Biotechnology Diabetes Enterprise Software Health Care

Top Investors

MedtroniceHealth VenturesMillhouseThe Leona M. and Harry B. Helmsley Charitable Trust

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about DreaMed Diabetes

How much funding has DreaMed Diabetes raised?

DreaMed Diabetes has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.

Who are DreaMed Diabetes's investors?

DreaMed Diabetes's investors include Medtronic, eHealth Ventures, Millhouse, The Leona M. and Harry B. Helmsley Charitable Trust.

Where is DreaMed Diabetes headquartered?

DreaMed Diabetes is headquartered in Petah Tiqva, Israel.

What does DreaMed Diabetes do?

DreaMed Diabetes offers AI solutions and personalized support for optimized insulin therapy.

What stage is DreaMed Diabetes at?

DreaMed Diabetes is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 19, 2024.

MLA

"DreaMed Diabetes — Funding & Investors." VCBacked, August 19, 2024, https://www.vcbacked.co/company/dreamed-diabetes. Accessed June 18, 2026.

APA

VCBacked. (2024). DreaMed Diabetes — Funding & Investors. Retrieved June 18, 2026, from https://www.vcbacked.co/company/dreamed-diabetes

Wikipedia (cite web)

{{cite web |title=DreaMed Diabetes — Funding & Investors |url=https://www.vcbacked.co/company/dreamed-diabetes |website=VCBacked |access-date=June 18, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 19, 2024.